Nevertheless, our results suggest a potential link between PDE4 and AMPK/NOX2 and that cGMP-PDEs, especially PDE1 and PDE2, may be interesting therapeutic targets in preventing cardiac hypertrophy. This evidence concerns the gene PRKAA2 and cardiac hypertrophy.